Information Provided By: 
Fly News Breaks for March 4, 2020
PODD
Mar 4, 2020 | 17:17 EDT
Citi analyst Joanne Wuensch initiated coverage of Insulet with a Buy rating and $220 price target. The analyst contends that the company is on the "threshold of the evolving diabetes treatment" as its tubeless OmniPod insulin pump can be placed on the body for 3 days. Wuensch believes the new technology is "meaningfully differentiating itself from traditional insulin pumps" and further points to increased patient utilization due to the Pod access through the pharmacy channel.
News For PODD From the Last 2 Days
There are no results for your query PODD
